Alpha Centric Advisors LLC Decibel Therapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 25, 2022
SELL
$4.57 - $8.58 $171,375 - $321,750
-37,500 Closed
0 $0
Q3 2021

Mar 09, 2022
SELL
$6.6 - $9.04 $49,500 - $67,800
-7,500 Reduced 16.67%
37,500 $289,000
Q2 2021

Mar 09, 2022
BUY
$6.39 - $11.51 $230,040 - $414,360
36,000 Added 400.0%
45,000 $387,000
Q1 2021

Mar 09, 2022
BUY
$10.56 - $19.9 $95,040 - $179,100
9,000 New
9,000 $102,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email